4.4 Article

Adoptive Antitumor Immunotherapy In Vitro and In Vivo Using Genetically Activated erbB2-specific T Cells

Journal

JOURNAL OF IMMUNOTHERAPY
Volume 37, Issue 7, Pages 351-359

Publisher

Ovid Technologies (Wolters Kluwer Health)
DOI: 10.1097/cji.0000000000000048

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available